The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EAU 2023 | EU Cancer Plan and what it means for prostate cancer
Tit Albreht, MD, PhD, National Institute of Public Health, Ljubljana, Slovenia, shares insight on implementing Europe’s Beating Cancer Plan and what it means for prostate cancer, providing an overview of each key component including primary prevention, screening, diagnosis, treatment and quality. This interview took place at the EAU congress in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
